Gaps Seen in Childhood Vision Screening, Vision Care
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- Gaps in access to childhood vision screening and vision care are prevalent among historically marginalized racial and ethnic groups and socioeconomically vulnerable families, according to a research letter published online Jan. 25 in JAMA Ophthalmology.
Isdin Oke, M.D., from Boston Children’s Hospital, and colleagues sought to identify gaps in the vision screening pathways for U.S. children. The analysis included data from 30,173 school-aged children (aged 6 to <18 years) participating in the 2021 National Survey of Children’s Health.
The researchers found that 61 percent of participants reported receiving vision screening within the last two years. Among those receiving screening, 30 percent were referred for an eye examination. The vast majority of those referred (92 percent) reported establishing care with a specialist. Children identifying as Hispanic, Asian, or Black and those residing in low-income households or with a non-English primary household language were less likely to receive screening, more likely to be referred for an eye examination, and less likely to establish care with a specialist. Similarly, adolescents, children without health insurance, and children with caregivers with less than high school education were less likely to receive screening and more likely to be referred for an eye examination.
"The current approach to vision screening in the United States may not adequately provide care to all children," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-31 22:15
Read more
- Can the Mediterranean Diet Boost Your Memory?
- Higher Intake of Red Meat Linked to Increased Risk for Dementia
- Men Are 3 Times As Likely to Die from Traumatic Brain Injury Compared to Women
- Dancing Helps People With Parkinson’s In More Ways Than One
- How To Handle Travel Stress
- FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions